NCT02590094View on ClinicalTrials.gov

Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV

NACompletedINTERVENTIONAL
Enrollment

568

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 4, 2019

Study Completion Date

January 4, 2019

Conditions
Diabetic Retinopathy
Interventions
DRUG

Intravitreal bevacizumab or intravitreal ziv-aflibercept

Intravitreal bevacizumab or intravitreal ziv-aflibercept is given preoperatively at various time intervals and doses.

Trial Locations (1)

Unknown

Hospital La Carlota, Montemorelos

All Listed Sponsors
lead

Panhandle Eye Group, LLP

OTHER

NCT02590094 - Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV | Biotech Hunter | Biotech Hunter